(HealthDay)—For patients with diabetic macular edema, repeated ranibizumab treatment does not appear to be associated with impaired macular perfusion, according to a study published online March 1 in JAMA Ophthalmology.
Mar 7, 2018
0
12
(HealthDay)—For patients with diabetic macular edema (DME), persistence is more likely with bevacizumab than with aflibercept or ranibizumab, according to a study published online Feb. 1 in JAMA Ophthalmology.
Feb 4, 2018
0
4
(HealthDay)—Diet soda consumption may up the odds of diabetic retinopathy (DR), according to a study published online Jan. 23 in Clinical & Experimental Ophthalmology.
Jan 30, 2018
0
25
Patients with age-related macular degeneration who received seven or more eye injections of the drug bevacizumab annually had a higher risk of having glaucoma surgery, according to a study published online by JAMA Ophthalmology.
Mar 16, 2017
0
18
(HealthDay)—Total retinal blood flow (TRBF) is significantly lower in eyes of patients with diabetic macular edema (DME), according to a study published online Feb. 9 in JAMA Ophthalmology.
Feb 13, 2017
0
0
The standard of care for treating strokes caused by blood clots involves the therapeutic infusion of tissue plasminogen activator (tPA), which can help to dissolve the clots and restore blood flow. This "thrombolytic" treatment ...
Jan 27, 2017
0
0
(HealthDay)—For eyes experiencing substantial visual loss after macular laser photocoagulation treatment for diabetic macular edema (DME), intravitreal aflibercept improves visual and anatomic outcomes, according to a study ...
Dec 29, 2016
0
0
In an evaluation of retinal photographs from adults with diabetes, an algorithm based on deep machine learning had high sensitivity and specificity for detecting referable diabetic retinopathy, according to a study published ...
Nov 29, 2016
0
1
In a study published online by JAMA Ophthalmology, Gwyneth Rees, Ph.D., of the University of Melbourne, Australia, and colleagues examined the association between severity of diabetic retinopathy and diabetic macular edema ...
Jul 7, 2016
0
4
The anti-vascular endothelial growth factor drugs ranibizumab and aflibercept, used to treat vision loss from diabetic macular edema (DME), and approximately 20 to 30 times more expensive than bevacizumab, are not cost-effective ...
Jun 9, 2016
0
0
